Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc (SNDX) Option Chain
As of September 22, 2026, Syndax Pharmaceuticals Inc is trading at $17.64, a -3.00% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 65.7%. IV Rank is 24%.
Read more
Tracking the SNDX option chain helps you see every strike and expiry on Syndax Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Syndax Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SNDX options activity at a glance. Use our scanner to monitor the SNDX option chain in real time and filter for the SNDX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SNDX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SNDX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SNDX stock options are being actively traded and where they are not.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat.
It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Syndax Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SNDX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SNDX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile40.08% Neutral
- Market cap (M$)1,575
- 52 weeks high-31.07%
- 52 weeks low35.80%
- Analyst recommendationStrong Buy
1.08 - Target price$37.55
112.87% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-02
- P/E—
- Future P/E—
- EPS (ttm)-2.52
- EPS growth next 5 years—
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 23.54 | 0 | 0 | 0.86 | 1.64 | 1.20 | 3.80 | 16.00 | -11.99 | 0.10 | 0.45 | 0.00 | 0.28 | 10 | 15 | 76.46 |
| 36.40 | 1 | 0 | 1.21 | 0.64 | 0.50 | 3.20 | 17.00 | -6.49 | — | 0.80 | 0.00 | 0.80 | 0 | 141 | 63.60 |
| 50.16 | 13 | 0 | 1.25 | 0.00 | 0.15 | 2.35 | 18.00 | -0.99 | — | 1.50 | 0.36 | 1.14 | 1 | 43 | 49.84 |
| 63.19 | 4 | 1 | 0.78 | 0.00 | 0.15 | 1.40 | 19.00 | +4.51 | 0.95 | 2.35 | 1.36 | 0.29 | 0 | 31 | 36.81 |
| 74.30 | 265 | 3 | 0.50 | 0.00 | 0.15 | 0.85 | 20.00 | +10.01 | 1.00 | 3.70 | 2.36 | -0.01 | 0 | 10 | 25.70 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full SNDX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→